Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis patients in Addis Ababa, Ethiopia from 2014 to 2021.
IJID Reg
; 5: 97-103, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-36247095
EPHI, Ethiopian Public Health Institute; EPTB, extrapulmonary tuberculosis; MDR, multidrug resistance; MTB, Mycobacterium tuberculosis; MTBC, Mycobacterium tuberculosis complex; Mycobacterium tuberculosis; NTRL, National Tuberculosis Reference Laboratory; PTB, pulmonary tuberculosis; RIF, rifampicin; RR-TB, rifampicin-resistant tuberculosis; SPSS, Statistical Package for Social Sciences; TB, tuberculosis; WHO, World Health Organization; Xpert MTB/RIF; frequency; rifampicin resistance
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
Language:
En
Journal:
IJID Reg
Year:
2022
Document type:
Article
Affiliation country:
Ethiopia
Country of publication:
United kingdom